![Manuel Llobet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manuel Llobet
Algemeen Directeur bij
ALLERGY THERAPEUTICS PLC
Vermogen: 386 943 $ op 31-08-2026
Profiel
Mr. Manuel Llobet is a Chief Executive Officer & Executive Director at Allergy Therapeutics Plc and a Managing Director at Bencard Allergie GmbH.
He is on the Board of Directors at Allergy Therapeutics Plc, Allergy Therapeutics (Holdings) Ltd. and Allergy Therapeutics (UK) Ltd. Mr. Llobet was previously employed as an Executive Director by Corporación Drokasa SA, a Manager-Business Development by Laboratorio Chile SA, and a Chief Executive Officer by Laboratorios Andrómaco SA. He received his undergraduate degree from Ramon Llull University and an MBA from the Instituto de Estudios Superiores de la Empresa.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2025 | 5.001.200 ( 0,08% ) | 386 943 $ | 31-08-2026 |
Actieve functies van Manuel Llobet
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Algemeen Directeur | 01-07-2009 |
Allergy Therapeutics (UK) Ltd.
 Allergy Therapeutics (UK) Ltd. Medical SpecialtiesHealth Technology Researches, develops and markets allergy treatment products | Directeur/Bestuurslid | - |
Bencard Allergie GmbH
 Bencard Allergie GmbH Medical SpecialtiesHealth Technology Researches and develops drugs for the diagnosis | Algemeen Directeur | - |
Allergy Therapeutics (Holdings) Ltd.
 Allergy Therapeutics (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | 01-10-2009 |
Eerdere bekende functies van Manuel Llobet
| Bedrijven | Functie | Einde |
|---|---|---|
Laboratorio Chile SA
 Laboratorio Chile SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
| LABORATORIOS ANDROMACO S.A. | President | - |
Corporación Drokasa SA
 Corporación Drokasa SA Wholesale DistributorsDistribution Services Distributes agricultural chemical products | Directeur/Bestuurslid | - |
Opleiding van Manuel Llobet
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Laboratorios Andrómaco SA
 Laboratorios Andrómaco SA Pharmaceuticals: MajorHealth Technology Produces and markets pharmaceutical products | Health Technology |
Laboratorio Chile SA
Laboratorio Chile SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Ramon Llull University
 Ramon Llull University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corporación Drokasa SA
Corporación Drokasa SA Wholesale DistributorsDistribution Services Distributes agricultural chemical products | Distribution Services |
Allergy Therapeutics (UK) Ltd.
Allergy Therapeutics (UK) Ltd. Medical SpecialtiesHealth Technology Researches, develops and markets allergy treatment products | Health Technology |
Allergy Therapeutics (Holdings) Ltd.
Allergy Therapeutics (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Instituto de Estudios Superiores de la Empresa
 Instituto de Estudios Superiores de la Empresa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bencard Allergie GmbH
Bencard Allergie GmbH Medical SpecialtiesHealth Technology Researches and develops drugs for the diagnosis | Health Technology |
